Zoetis
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Jersey, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
10 Sylvan Way, Parsippany, New Jersey, 0...Phone Number
(888) 963-8471Website
www.zoetis.comRevenue
$9.5 BillionStock Symbol
ZTSIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
3
3
2
2
1
About Zoetis
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. It markets to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company is headquartered in Parsippany, New Jersey.Explore more
Zoetis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Zoetis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Zoetis, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Zoetis launches new products
Funding: Get notified immidiatlly once Zoetis has new funding data
Click to see if Zoetis had a recent Job posting/layoffs
Check if Zoetis has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Zoetis recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Zoetis
Check out if Zoetis is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Zoetis
Compare insights from companies similar to Zoetis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Zoetis
$9.5B
10K+
Public
$2.3B
1952
RV
Renato Vilas BoasRegional Chief Financial Officer, Latin America (Canada)
Company Profile Activity
Activity Insights
Zoetis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Zoetis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Zoetis.
Zoetis financials insights
Gather financial insights about Zoetis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$2.2B
2023
Grant
$15.3M
Zoetis Tech Stack
A closer look at the technologies used by Zoetis
Most Recent Scoops
Open Position
Open Position
Open Position
Person-Based
Product Launch, Pharmaceuticals
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Zoetis News & Media
Zoetis (ZTS) Looked Like a Winner. What Went Wrong?
Brown Advisory, an investment management company, released its “Brown Advisory Global Leaders Strategy” for the second quarter of 2026 investor letter. A copy of the letter can be downloaded here. Brown Advisory’s Global Leaders Strategy delivered a net return of 4.6% in the second quarter of 2026, underperforming its benchmark, the MSCI ACWI Net Index, […]Zoetis Q2 Earnings Call Highlights
Zoetis (NYSE:ZTS) reported second-quarter revenue of $2.5 billion, flat on a reported basis and down 1% organically, as pressure in U.S. companion-animal categories offset growth in livestock, diagnostics and international markets. Adjusted net income was $781 million, down 2% organically, while adjZoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer
Saccaro’s Appointment is Effective August 17, 2026; Wetteny Joseph to Serve as a Special Advisor to the CEO on Financial Matters Until Early 2027 Zoetis Inc. (NYSE: ZTS) today announced the appointment of James (Jay) Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026. In this newly created role, Mr. Saccaro will lead Zoetis’ global finance function, shaping capital allocation, financial strategy, reporting and controls, and investoZoetis Inc. (ZTS) Q2 2026 Earnings Call Transcript
Zoetis Inc. (ZTS) Q2 2026 Earnings Call August 6, 2026 8:30 AM EDTCompany ParticipantsSteven Frank - Vice President of Investor RelationsKristin Peck - CEO...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zoetis
Sign Up For FreeTo access detailed company insights
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The comp... Read More
